News and Stories About precision medicine

Clinical trials are testing new treatment approaches and becoming more innovative.

Thanks to you, we’re making progress toward early detection and better treatments.

Conference featured exciting new results, robust discussion and a look to the future.

PanCAN and partners published a study about RAF alterations in patients’ tumors.

Editor’s note: Originally published in February 2021, we’ve updated this article to include the exciting news that the first drug […]
READ MORE

The 2021 Gastrointestinal (GI) Cancers Symposium recently brought together oncologists, researchers, patients and patient advocates, including the Pancreatic Cancer Action […]
READ MORE

Editor’s note: Today’s article looks back at scientific and clinical advances made in 2020 and kicks off our Year in […]
READ MORE

Get a recap of our World Pancreatic Cancer Day webinar featuring an expert panel discussing the latest in clinical research […]

If you have a first-degree relative (parent, child or sibling) who was diagnosed with pancreatic cancer, you may have an […]
READ MORE

Editor’s note: It’s Rare Cancer Day, so we thought we’d take the opportunity to talk about how rare pancreatic cancer […]
READ MORE

In its latest guidelines for the treatment of patients with metastatic pancreatic cancer, the American Society of Clinical Oncology (ASCO) […]
READ MORE

Editor’s note: “Jeopardy!” host Alex Trebek and former Sen. Harry Reid have publicly mentioned being treated with an experimental immunotherapy […]
READ MORE

A drug that received unprecedented approval in the U.S. three years ago is now available for even more patients. In […]
READ MORE

Editor’s note: Earlier this year, we featured Steven Merlin’s amazing dedication as a Pancreatic Cancer Action Network (PanCAN) volunteer and […]
READ MORE

You are your own best advocate. If you’ve been diagnosed with a disease like pancreatic cancer, it’s important to get […]
READ MORE

The theme for the 2020 American Society of Clinical Oncology’s (ASCO) Annual Meeting was “Unite & Conquer: Accelerating Progress Together.” […]
READ MORE

About one in four pancreatic cancer patients have changes in their tumor that suggest certain treatments may work particularly well […]
READ MORE

A recent paper published in the prestigious journal Lancet Oncology showed that the Pancreatic Cancer Action Network’s (PanCAN) Know Your […]
READ MORE

Pancreatic Cancer Action Network and Perthera Study in Lancet Oncology Underscores the Urgent Need for Every Pancreatic Cancer Patient to […]
READ MORE

The Pancreatic Cancer Action Network’s (PanCAN) Know Your Tumor® precision medicine service can help pancreatic cancer patients live longer. Know […]
READ MORE

Stage IV pancreatic cancer survivor Ken Harding was no longer having great results after nine months on standard chemotherapy.  But […]
READ MORE

“Accelerating Personalized Care” was the theme for the 2020 Gastrointestinal (GI) Cancers Symposium, which took place Jan. 23-25 in San […]
READ MORE

Editor’s note: Sadly, Gina passed away in January 2021. We are so grateful she shared her story to inspire and […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Today we share the experience of a stage IV pancreatic […]
READ MORE

The Food and Drug Administration (FDA) recently approved the treatment Lynparza® (olaparib) for use in a group of pancreatic cancer […]
READ MORE

Today the U.S. Food and Drug Administration (FDA) approved the targeted therapy Lynparza® (olaparib) for the treatment of patients who […]
READ MORE

Editor’s note: This article kicks off our 2019 Year in Review series – highlighting the research advancements that you – […]
READ MORE

Editor’s note: Mary Fox passed away in January 2020. We are grateful she allowed her story to be shared. In […]
READ MORE

People with pancreatic cancer and a specific type of change – or mutation – in their DNA live longer when […]
READ MORE

Editor’s note: We are deeply saddened to share that Adam Deal died of pancreatic cancer in December 2020. His advocacy […]
READ MORE

When the Pancreatic Cancer Action Network (PanCAN) launched its Know Your Tumor® precision medicine service, molecular profiling was offered for […]
READ MORE

It’s Cancer Immunotherapy Month. Here, we discuss immunotherapy and pancreatic cancer.

Every pancreatic tumor – and every pancreatic cancer patient – is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends […]
READ MORE

This year’s American Society of Clinical Oncology (ASCO) Annual Meeting has brought 40,000 oncologists and other cancer experts from around […]
READ MORE

The morning of Feb. 5, 2016, started like many for Gail. She got up early and headed to the gym […]
READ MORE

An imaging test may find a tumor on the pancreas, which could be benign (non-cancerous) or malignant (cancerous). Getting a […]
READ MORE

Editor’s note: The National Comprehensive Cancer Network (NCCN), which sets guidelines for the treatment and management of pancreatic adenocarcinoma (the […]
READ MORE

“I’ve been attending the American Association for Cancer Research (AACR) annual meetings for several years, and this year’s conference was […]
READ MORE

About 10 percent of pancreatic cancer cases are thought to be hereditary – caused by an inherited genetic alteration that […]
READ MORE

The largest-ever molecular analysis of pancreatic cancer tissue samples – from more than 3,500 patients – revealed some new clues […]
READ MORE

When Allison Perlis of Potomac, Md., first began experiencing symptoms of pancreatic cancer in early 2017, she dismissed them as […]
READ MORE

Around Christmas 2016, Karen Kiernan was enjoying the holidays at her family home in Truckee, Calif., when she began to […]
READ MORE

A recently published article on TIME.com highlights important steps patients should take after a cancer diagnosis and mentions that the […]
READ MORE

Last week, Jenny Isaacson, vice president of strategic partnerships and projects at the Pancreatic Cancer Action Network (PanCAN), championed cross-sector […]
READ MORE

Editor’s note: Welcome to the first article in our 2018 Year in Review series! Over the next couple weeks, we’ll […]
READ MORE

Elise Tedeschi was shocked when she was diagnosed with stage IV pancreatic cancer. She was only 42 years old, enjoying […]
READ MORE

The U.S. Food and Drug Administration (FDA) approved Vitrakvi® (larotrectinib) today for the treatment of any locally advanced or metastatic solid tumor, […]
READ MORE

The Atlantic’s People v. Cancer event took place Nov. 14, 2018, in New York City. The event featured a stellar […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) offers an Ask PanCAN Patient Services series to provide helpful tips and information about […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) has now delivered personalized molecular profiling reports to 1,000 pancreatic cancer patients through its […]
READ MORE

“I was 7 years old when my dad’s mom, Gertrud, was diagnosed with breast cancer,” began Pamela Munster, MD, a […]
READ MORE

When doctors told David Watson of Santa Monica, Calif., that he had type 2 diabetes in November 2016, he couldn’t […]
READ MORE

A biomarker is a substance found in the body that can be measured. The amount of a biomarker may vary […]
READ MORE

The fitting theme for this year’s Pancreatic Cancer Action Network (PanCAN) Annual Scientific Summit, occurring Aug. 23-26, 2018, in San […]
READ MORE

Before Allison Lippman of Dallas met her now-husband, she was not convinced she wanted to date anyone. “I was turning […]
READ MORE

Editor’s note, March 2, 2020: Results published in Lancet Oncology from the Pancreatic Cancer Action Network’s (PanCAN) Know Your Tumor® […]
READ MORE

Cancer immunotherapy involves efforts to harness the patient’s own immune system to recognize and attack tumor cells. To date, the […]
READ MORE

Published today in the esteemed Clinical Cancer Research, a journal of the American Association for Cancer Research, the Pancreatic Cancer […]
READ MORE

With the Identification of Six Genetic Mutations, Authors Urge Genetic Testing for All Pancreatic Cancer Patients – Not Only Those […]
READ MORE

A pancreatic cancer diagnosis can lead to a lot of questions, including how to choose a healthcare team, deciding on […]
READ MORE

Every pancreatic tumor is different. The Pancreatic Cancer Action Network (PanCAN) strongly recommends molecular profiling of your tumor to help […]
READ MORE

It is important to know all your treatment options at every stage of your pancreatic cancer diagnosis. Here are five […]
READ MORE

The American Society of Clinical Oncology (ASCO) has updated their treatment guidelines for patients with metastatic pancreatic cancer, or disease […]
READ MORE

Editor’s note: Below we describe recent updates to the National Comprehensive Cancer Network’s (NCCN) guidelines for the treatment and management […]
READ MORE

Did you know that DNA gets its own day? It’s today! National DNA Day has been celebrated since 2003, when […]
READ MORE

The theme for this year’s American Association for Cancer Research (AACR) Annual Meeting, which took place earlier this week in […]
READ MORE

In a recent Forbes article, “She Was Given Three Years To Live. So She Transformed Cancer Research,” Pancreatic Cancer Action […]
READ MORE

Editor’s note: Today is National Doctors’ Day, and we are celebrating the critical roles of various specialists in the diagnosis […]
READ MORE

About 95 percent of pancreatic cancer cases – and around 30 percent of all human cancers – have a mutation […]
READ MORE

“All Cancer Patients Should Have Access To Genomic Testing” is the title of a compelling article featured in Forbes earlier […]
READ MORE

Editor’s note: This article is another installment in our “Year in Review” series recapping the year’s top stories in pancreatic […]
READ MORE

At the end of every year, Science magazine announces a Breakthrough of the Year – a discovery that revolutionized the […]
READ MORE

Editor’s note: This article is the first in our “Year in Review” series recapping the year’s top stories in pancreatic […]
READ MORE

Akshay Mehta, MD, was in the middle of performing an orthopedic surgery when his first pancreatic cancer symptom arose. “I […]
READ MORE

Among the many genetic mutations and molecular alterations that can be found in pancreatic tumors, there are four that are […]
READ MORE

Pancreatic cancer is difficult to treat. There are a few standard treatments, but there are additional options that we encourage […]
READ MORE

“Let’s face it: The pancreas is a behind-the-scenes organ most of us don’t know – or think – much about. […]
READ MORE

The American Association for Cancer Research (AACR) released its annual Cancer Progress Report earlier this week. “Research continues to be […]
READ MORE

The so-called breast cancer genes BRCA1 and BRCA2 were originally found to increase a woman’s risk of breast cancer when […]
READ MORE

The cleverly named The Cancer Genome Atlas project – abbreviated TCGA, in homage to the four base pairs that make […]
READ MORE

Every pancreatic tumor is different. The Pancreatic Cancer Action Network strongly recommends molecular profiling of your tumor to help determine […]
READ MORE

Pancreatic Cancer Action Network invests in precision medicine and early detection to change outcomes for the world’s toughest cancer MANHATTAN […]
READ MORE

Editor’s note: Keytruda was the first cancer drug approved to treat any solid tumor – anywhere in the body – […]
READ MORE

May was a busy month for pancreatic cancer precision medicine developments. Every pancreatic tumor is different. The Pancreatic Cancer Action […]
READ MORE

Editor’s note: Sadly, Josephine Scivoli passed away in November 2019. We are grateful she allowed her story to be shared. Josephine […]
READ MORE

The American Association for Cancer Research (AACR) is spearheading a large-scale molecular profiling effort called Project Genomics Evidence Neoplasia Information […]
READ MORE

Last week, we shared the exciting news that an immunotherapy agent, Keytruda, was the first drug approved by the FDA […]
READ MORE

For the first time, the U.S. Food and Drug Administration (FDA) has approved a cancer drug based only on molecular […]
READ MORE

The Pancreatic Cancer Action Network’s state-of-the-art Know Your Tumor® precision medicine service offers molecular profiling to eligible patients. Molecular profiling […]
READ MORE

Making treatment decisions may be overwhelming. We want to make sure you have the information you need, every step of […]
READ MORE

Revolutionary Clinical Trial Initiative Focuses On Precision Medicine, Collaboration and Data Sharing to Transform Outcomes for All Pancreatic Cancer Patients […]
READ MORE

Dr. Andrew E. Hendifar, the medical oncology lead for the gastrointestinal disease research group at Cedars-Sinai Medical Center, champions progress […]
READ MORE

We’ve learned a lot about pancreatic cancer in recent years, and we now know that every patient’s cancer is different […]
READ MORE